Viewing Study NCT05965167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:55 AM
Ignite Modification Date: 2026-05-05 @ 5:09 AM
Study NCT ID: NCT05965167
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2023-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo
Sponsor: Entera Bio Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypoparathyroidism View
None Osteoporosis View
None Fractures, Bone View
None Other Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypoparathyroidism View
None PTH(1-34) View
None Parathyroid Hormone View
None Teriparatide View
None Osteoporosis View